- Report
- April 2025
- 210 Pages
Global
From €4041EUR$4,500USD£3,461GBP
- Report
- March 2025
- 197 Pages
Global
From €4445EUR$4,950USD£3,807GBP
- Report
- March 2025
- 110 Pages
Global
From €2649EUR$2,950USD£2,269GBP
- Report
- December 2024
- 150 Pages
Global
From €3368EUR$3,750USD£2,884GBP
- Report
- May 2025
- 125 Pages
United States
From €2919EUR$3,250USD£2,500GBP
- Report
- October 2024
- 200 Pages
United States
From €2236EUR$2,490USD£1,915GBP
- Report
- October 2024
- 200 Pages
Europe
From €2236EUR$2,490USD£1,915GBP
- Report
- March 2025
- 120 Pages
North America
From €3053EUR$3,400USD£2,615GBP
€3592EUR$4,000USD£3,077GBP
- Report
- August 2024
- 80 Pages
United States
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- July 2024
- 97 Pages
Africa, Middle East
From €3098EUR$3,450USD£2,654GBP
- Report
- May 2025
- 84 Pages
United States
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- January 2025
- 97 Pages
Middle East, Africa
From €3098EUR$3,450USD£2,654GBP
- Report
- January 2025
- 104 Pages
North America
From €3098EUR$3,450USD£2,654GBP
- Report
- October 2024
- 114 Pages
North America
From €3098EUR$3,450USD£2,654GBP
- Report
- October 2024
- 109 Pages
Middle East, Africa
From €3098EUR$3,450USD£2,654GBP
- Report
- October 2024
- 126 Pages
Europe
From €3098EUR$3,450USD£2,654GBP
- Report
- May 2025
- 145 Pages
United States
From €2245EUR$2,500USD£1,923GBP
- Report
- March 2025
- 82 Pages
Middle East, Africa
From €2649EUR$2,950USD£2,269GBP
- Report
- March 2025
- 96 Pages
Asia Pacific
From €3098EUR$3,450USD£2,654GBP
- Report
- March 2025
- 99 Pages
Europe
From €3098EUR$3,450USD£2,654GBP

Retinopathy is a medical condition that affects the retina, the light-sensitive tissue at the back of the eye. It is a leading cause of blindness and visual impairment worldwide. Optical treatments for retinopathy include laser photocoagulation, intravitreal injections, and vitrectomy. Laser photocoagulation is used to reduce the risk of vision loss by sealing off leaking blood vessels in the retina. Intravitreal injections are used to deliver medications directly to the retina to reduce swelling and inflammation. Vitrectomy is a surgical procedure used to remove scar tissue and other debris from the vitreous cavity.
Companies in the retinopathy market include Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Heidelberg Engineering, Nidek, Optos, Topcon, and Zeiss. Show Less Read more